Latest Blogs

Apr 22, 2024
We appreciate your continued commitment to our field, your dedication to the Society and Association missions, and the invaluable leadership and insight that you add.
Apr 16, 2024
Following a HemOncFellows’ Network discussion on common questions aspiring and current fellows have about oncology fellowship, 10 participants, organizers, and members share practical advice that you can use in preparing for your fellowship.
Apr 09, 2024
How should an oncologist investigate a career change? How does one find their second or third job out of training? Here are some strategies to consider.
Apr 04, 2024
"To any medical students and residents who have a spark for oncology, I cannot recommend the VMP enough," said Zain Ahmad. "It is an experience that could change the trajectory of your career."
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine and professor of surgery at Brown University, director of the Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. He also serves as the head of community outreach and engagement of the Legorreta Cancer Center at Brown University. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational Book. Follow Dr. Dizon across social media channels @drdonsdizon. 

Disclosure.

Mar 22, 2012
Earlier this week I passed my friend and colleague, Dr. Ekaterini Tsiapali, in the stairwell. We rarely get to catch up these days, so it was really quite a nice surprise to see her."What...
Mar 10, 2012
I have to admit it. Even today, I find interpreting statistics for patients very difficult; not because I don't understand the concept of relative and absolute risks, hazard or odds ratios, or survival rates. It's because in the end, they do not apply at an individual level.
Feb 11, 2012
The controversy that has erupted regarding the Susan G. Komen foundation and recent decisions about funding Planned Parenthood has been hard to miss. As a specialist in women's cancers and given my general interest in women's health, I've been fascinated by this dialogue online—on message boards,...
Feb 04, 2012
Last week I attended the semi-annual meeting of the Gynecologic Oncology Group, the cooperative group focused on trials for gynecologic cancers. Over two days I was engaged in updates of ongoing clinical trials and discussion of new trial concepts for ovarian,...
Jan 24, 2012
When I tell people I am an oncologist, I usually get the same response: "That must be so depressing! How do you stand it?" I remember having members of my own family ask me that way back when I was a medical resident as I made the decision to enter oncology. Now that I am in a position where I...
Jan 10, 2012
Recently, a very dear friend learned that her breast cancer (diagnosed in 2010) had spread to her brain. Despite my many years as an oncologist, having faced questions from my own patients about "Why me?", "What did I do to deserve this?"—questions I am fully aware have no answer—I found myself...

Pages